Loading organizations...
Key people at Beecken Petty O'Keefe & Company.
Beecken Petty O’Keefe & Company (BPOC) is an investment firm that provides capital solutions to middle-market healthcare companies. It partners with founders and operators of businesses demonstrating strong performance, defensible market positions, and attractive growth outlooks. BPOC leverages an extensive industry network and experienced operating partners to support portfolio companies through market challenges.
BPOC was established in 1996 by its founders, Dave Beecken, Bill Petty, and Ken O’Keefe. Their foundational insight led to the creation of a dedicated healthcare-focused investment firm, drawing on their significant sector experience. The firm has since grown its leadership, with its senior investment team maintaining substantial tenure and deep expertise.
The firm primarily serves middle-market, often founder-led, healthcare companies. BPOC’s vision focuses on being a valued partner to healthcare leaders, aligning with them in pursuit of growth and value creation. They cultivate trusting and transparent relationships, aiming to support the legacies of the businesses they help build.
Beecken Petty O'Keefe & Company has 2 tracked investments across 1 company. The latest tracked deal is $70.0M Series B in Aptinyx in December 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2017 | Aptinyx | $70.0M Series B | Bain Capital Life Sciences | 5AM Ventures, Access Biotechnology, Longwood Fund, Adage Capital Management, Adams Street Partners, Agent Capital, Frazier Healthcare Partners, Goudy Park Capital, HBM Healthcare Investments, Longitude Capital, LVP Life Science Ventures, NAN Fung Life Sciences, NEW Leaf Venture Partners, Northwestern University, Osage University Partners, Partner Fund Management, Pathocapital, Rock Springs Capital |
| May 1, 2016 | Aptinyx | $65.0M Series A | Liam Ratcliffe | Access Biotechnology, Adams Street Partners, James Topper, Goudy Park Capital, Patrick Enright, LVP Life Science Ventures, Northwestern University, Osage University Partners, Pathocapital |
Key people at Beecken Petty O'Keefe & Company.